SCHEMBL6804085

SCHEMBL6804085

Nc1ccc(CCNS(=O)(=O)c2ccccc2)cc1

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT1 Q99873 2/20 0.88
ALDH1A1 P00352 7/20 0.74
CA1 P00915 2/20 0.74
CA2 P00918 2/20 0.74
CA12 O43570 1/20 0.74
CA6 P23280 1/20 0.74
CA5A P35218 1/20 0.74
CA7 P43166 1/20 0.74
CA9 Q16790 1/20 0.74
CA14 Q9ULX7 1/20 0.74
CA5B Q9Y2D0 1/20 0.74
TDP1 Q9NUW8 1/20 0.67
HSD17B10 Q99714 1/20 0.67
TAAR1 Q96RJ0 1/20 0.62
MAPT P10636 1/20 0.61
TBXA2R P21731 1/20 0.59
TBXAS1 P24557 1/20 0.59
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
POLB P06746 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3849081 0.93 PRMT1 (1.00) PRMT1ALDH1A1CA1CA2CA12
SCHEMBL412302 0.88 ALDH1A1 (0.79) PRMT1ALDH1A1CA1CA2TDP1
Hydrochloric Acid SCHEMBL3517769 0.86 ALDH1A1 (0.77) PRMT1ALDH1A1CA1CA2TDP1
SCHEMBL2850435 0.86 PRMT1 (0.83) PRMT1ALDH1A1CA1CA2CA12
SCHEMBL13030968 0.85 CA1 (1.00) PRMT1ALDH1A1CA1CA2CA12
SCHEMBL6974335 0.84 MEN1 (0.78) PRMT1ALDH1A1CA1CA2CA12
SCHEMBL6803886 0.84 ALDH1A1 (0.84) PRMT1ALDH1A1CA1CA2CA12
SCHEMBL14156120 0.83 ALDH1A1 (0.84) PRMT1ALDH1A1CA1CA2CA12
SCHEMBL11340654 0.83 ALDH1A1 (0.69) PRMT1ALDH1A1CA1CA2TDP1
SCHEMBL10460741 0.83 ALDH1A1 (0.69) PRMT1ALDH1A1CA1CA2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114181133-B Preparation method of glycine derivative acetamide compound 上海应用技术大学 2023-04-28 CN disclosed
WO-2004074238-A1 PHENETHYLAMINO SULFAMIC ACIDS THE PROCTER & GAMBLE COMPANY (US) 2004-09-02 WO disclosed
US-20040167183-A1 Phenethylamino sulfamic acids THE PROCTER & GAMBLE COMPANY 2004-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167183-A1 Phenethylamino sulfamic acids PTPRM, PTPRS, PTPRE PRMT1 1332/4885ALDH1A1 622/4885CA1 2299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.